Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024
Union Korea Pharm Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,124 | 4,324 | 6,579 | 6,012 | 20,659 |
Short-Term Investments | 3,456 | 1,437 | 602.13 | 1,513 | 461.34 |
Cash & Short-Term Investments | 6,581 | 5,761 | 7,181 | 7,524 | 21,120 |
Cash Growth | 14.23% | -19.77% | -4.57% | -64.37% | 573.86% |
Accounts Receivable | 7,462 | 20,435 | 33,520 | 33,092 | 26,147 |
Other Receivables | 1,008 | 377.44 | 748.69 | 631.13 | 644.7 |
Receivables | 8,470 | 20,812 | 34,269 | 33,723 | 26,792 |
Inventory | 5,387 | 12,880 | 7,910 | 12,731 | 10,747 |
Prepaid Expenses | 142.42 | 152.38 | 91.99 | 76.39 | 69.3 |
Other Current Assets | 970.37 | 597.6 | 230.35 | 515.5 | 53.99 |
Total Current Assets | 21,550 | 40,202 | 49,683 | 54,570 | 58,782 |
Property, Plant & Equipment | 21,779 | 28,659 | 34,596 | 44,613 | 43,787 |
Long-Term Investments | 624.96 | 1,534 | 2,617 | 2,450 | 2,454 |
Other Intangible Assets | 609.8 | 742.14 | 1,081 | 1,539 | 1,751 |
Long-Term Deferred Tax Assets | - | 3,037 | 4,973 | 8,710 | 10,564 |
Other Long-Term Assets | 1,272 | 585.29 | 1,266 | 399.86 | 1,436 |
Total Assets | 45,836 | 74,910 | 94,425 | 112,523 | 119,044 |
Accounts Payable | 5,455 | 3,407 | 2,884 | 3,080 | 2,697 |
Accrued Expenses | 3,550 | 1,457 | 1,574 | 1,013 | 950.45 |
Short-Term Debt | 18,100 | 20,488 | 34,902 | 33,966 | 10,500 |
Current Portion of Long-Term Debt | 2,988 | 3,000 | 1,200 | - | 4,000 |
Current Portion of Leases | 249.48 | 273.55 | 167.26 | 127.24 | 280 |
Other Current Liabilities | 33,581 | 35,377 | 18,282 | 20,806 | 24,793 |
Total Current Liabilities | 63,924 | 64,003 | 59,009 | 58,992 | 43,220 |
Long-Term Debt | - | - | 3,000 | 3,000 | 21,026 |
Long-Term Leases | 96.07 | 230.99 | 80.13 | 31.79 | 61.48 |
Pension & Post-Retirement Benefits | 1,353 | 1,859 | 1,526 | 1,278 | 615.43 |
Other Long-Term Liabilities | 3,365 | 611.17 | 486.02 | 608.58 | 522.72 |
Total Liabilities | 68,737 | 66,704 | 64,101 | 63,910 | 65,445 |
Common Stock | 3,956 | 3,956 | 3,955 | 3,952 | 3,952 |
Additional Paid-In Capital | 47,339 | 47,339 | 47,324 | 47,299 | 47,299 |
Retained Earnings | -65,739 | -34,977 | -13,717 | 4,654 | 5,663 |
Treasury Stock | -7,309 | -7,309 | -7,309 | -7,309 | -4,592 |
Comprehensive Income & Other | -1,148 | -804.32 | 70.88 | 16.38 | 18.9 |
Total Common Equity | -22,901 | 8,205 | 30,324 | 48,612 | 52,341 |
Shareholders' Equity | -22,901 | 8,205 | 30,324 | 48,612 | 53,599 |
Total Liabilities & Equity | 45,836 | 74,910 | 94,425 | 112,523 | 119,044 |
Total Debt | 21,433 | 23,993 | 39,349 | 37,125 | 35,867 |
Net Cash (Debt) | -14,853 | -18,232 | -32,169 | -29,601 | -14,747 |
Net Cash Per Share | -2054.42 | -2522.59 | -4455.02 | -4011.66 | -1897.72 |
Filing Date Shares Outstanding | 7.23 | 7.23 | 7.23 | 7.22 | 7.56 |
Total Common Shares Outstanding | 7.23 | 7.23 | 7.23 | 7.22 | 7.56 |
Working Capital | -42,373 | -23,801 | -9,327 | -4,422 | 15,562 |
Book Value Per Share | -3167.51 | 1134.97 | 4196.34 | 6732.64 | 6925.43 |
Tangible Book Value | -23,511 | 7,463 | 29,243 | 47,073 | 50,590 |
Tangible Book Value Per Share | -3251.86 | 1032.31 | 4046.81 | 6519.47 | 6693.77 |
Land | 6,905 | 6,905 | 6,905 | 6,681 | 6,656 |
Buildings | 13,714 | 17,078 | 19,817 | 24,223 | 25,073 |
Machinery | 636.42 | 1,234 | 1,885 | 3,450 | 4,732 |
Construction In Progress | 130.5 | 2,902 | 5,382 | 9,172 | 5,512 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.